Cargando…

Impact of chemotherapy in the prognosis of non-small-cell lung cancer patients with severe to very severe COPD

BACKGROUND: The aim of the study was to investigate if first-line chemotherapy improves total survival time in non-small-cell lung cancer (NSCLC) patients complicated with severe to very severe COPD. MATERIALS AND METHODS: This retrospective observational clinical study included 267 consecutive NSCL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Weigang, Du, Yan, Ma, Shuping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254538/ https://www.ncbi.nlm.nih.gov/pubmed/30538442 http://dx.doi.org/10.2147/COPD.S182173

Ejemplares similares

Impact of mild to moderate COPD on feasibility and prognosis in non-small cell lung cancer patients who received chemotherapy
por: Omote, Norihito, et al.
Publicado: (2017)

Risk factors for cardiovascular disease in patients with COPD: mild-to-moderate COPD versus severe-to-very severe COPD
por: Caram, Laura Miranda de Oliveira, et al.
Publicado: (2016)

Sarcopenia in COPD: relationship with COPD severity and prognosis
por: Costa, Tatiana Munhoz da Rocha Lemos, et al.
Publicado: (2015)

The Level of Cholesterol in COPD Patients with Severe and Very Severe Stage of the Disease
por: Zafirova-Ivanovska, Beti, et al.
Publicado: (2016)

The Prevalence of Diabetes Mellitus in COPD Patients with Severe and Very Severe Stage of the Disease
por: Stojkovikj, Jagoda, et al.
Publicado: (2016)

Cost-effectiveness and healthcare budget impact in Italy of inhaled corticosteroids and brochodilators for severe and very severe COPD patients
por: Negro, Roberto Dal, et al.
Publicado: (2007)

Overall survival of driver mutation-negative non-small cell lung cancer patients with COPD under chemotherapy compared to non-COPD non-small cell lung cancer patients
por: Lim, Jeong Uk, et al.
Publicado: (2018)

Cost-effectiveness of roflumilast in combination with bronchodilator therapies in patients with severe and very severe COPD in Switzerland
por: Samyshkin, Yevgeniy, et al.
Publicado: (2013)

Early efficacy of budesonide/formoterol in patients with moderate-to-very-severe COPD
por: Calverley, Peter M, et al.
Publicado: (2016)

SBRT Treatment of Metachronous Small-Cell and Non-Small-Cell Lung Carcinomas in a Patient with Severe COPD
por: Duimering, Adele, et al.
Publicado: (2015)

Effects of exercise-based pulmonary rehabilitation on severe/very severe COPD: a systematic review and meta-analysis
por: He, Wenqing, et al.
Publicado: (2023)

Impact of cardiovascular comorbidities on COPD Assessment Test (CAT) and its responsiveness to pulmonary rehabilitation in patients with moderate to very severe COPD: protocol of the Chance study
por: Smid, Dionne E, et al.
Publicado: (2015)

Effect of COPD on symptoms, quality of life and prognosis in patients with advanced non-small cell lung cancer
por: Yi, Young-Soo, et al.
Publicado: (2018)

Impact of COPD on prognosis of lung cancer: from a perspective on disease heterogeneity
por: Wang, Wei, et al.
Publicado: (2018)

Comparison of disease-severity measures within severe and very severe COPD patients: results from a nationally representative chart review and patient survey
por: Solem, Caitlyn T, et al.
Publicado: (2014)

A Post Hoc Holter ECG Analysis of Olodaterol and Formoterol in Moderate-to-Very-Severe COPD
por: Andreas, Stefan, et al.
Publicado: (2020)

Impact of COPD Treatment on Survival in Patients with Advanced Non-Small Cell Lung Cancer
por: Jo, Hyunji, et al.
Publicado: (2022)

Elevated Stratifin promotes cisplatin-based chemotherapy failure and poor prognosis in non-small cell lung cancer
por: Ma, Yu-Shui, et al.
Publicado: (2021)

Determining the prevalence and severity of cancer cachexia in advanced non-small cell lung cancer and its relationship with chemotherapy outcomes
por: White, Rhys, et al.
Publicado: (2020)

Evaluation of the Characteristics of Asthma in Severe and Extremely Severe COPD
por: Chen, Feng-jia, et al.
Publicado: (2019)

Lung on fire: a very severe case of fire-eater’s lung
por: Nicolardi, Maria Luisa, et al.
Publicado: (2022)

Central arterial stiffness is increased among subjects with severe and very severe COPD: report from a population-based cohort study
por: Qvist, Linnea, et al.
Publicado: (2015)

CMTM1_v17 is associated with chemotherapy resistance and poor prognosis in non-small cell lung cancer
por: Si, Jiahui, et al.
Publicado: (2017)

Effect of joint mobilization and stretching on respiratory function and spinal movement in very severe COPD with thoracic kyphosis
por: Wang, Joong-San
Publicado: (2015)

Acute bronchodilator responses decline progressively over 4 years in patients with moderate to very severe COPD
por: Tashkin, Donald P, et al.
Publicado: (2014)

Long-term safety of tiotropium/olodaterol in older patients with moderate-to-very-severe COPD in the TONADO® studies
por: Ferguson, Gary T., et al.
Publicado: (2020)

Impact of air pollution on severe acute exacerbation of COPD
por: Haider, Miqdad, et al.
Publicado: (2018)

Impact of bronchiectasis on the frequency and severity of respiratory exacerbations in COPD
por: Labaki, Wassim W, et al.
Publicado: (2018)

Quantitative CT of Normal Lung Parenchyma and Small Airways Disease Topologies are Associated With COPD Severity and Progression
por: Bell, Alexander J., et al.
Publicado: (2023)

Clinical impact of prevalence and severity of COPD on the decision-making process for therapeutic management of lung cancer patients
por: Hashimoto, Naozumi, et al.
Publicado: (2014)

Intra- and inter-rater reproducibility of the 6-minute walk test and the 30-second sit-to-stand test in patients with severe and very severe COPD
por: Hansen, Henrik, et al.
Publicado: (2018)

Inter-Day Test–Retest Reproducibility of the CAT, CCQ, HADS and EQ-5D-3L in Patients with Severe and Very Severe COPD
por: Hansen, Henrik, et al.
Publicado: (2021)

Fetuin-B (FETUB): a Plasma Biomarker Candidate Related to the Severity of Lung Function in COPD
por: Diao, Wen-qi, et al.
Publicado: (2016)

Chemotherapy of non-small cell lung cancer.
por: Williams, C. J.
Publicado: (1989)

The Expression of NOX4 in Smooth Muscles of Small Airway Correlates with the Disease Severity of COPD
por: Liu, Xianyan, et al.
Publicado: (2016)

Association of microRNA-33a Molecular Signature with Non-Small Cell Lung Cancer Diagnosis and Prognosis after Chemotherapy
por: Hou, Li-Kun, et al.
Publicado: (2017)

Heterogeneous prognosis and adjuvant chemotherapy in pathological stage I non-small cell lung cancer patients
por: Liu, Chia-Hsin, et al.
Publicado: (2015)

Smoking cessation before initiation of chemotherapy in metastatic non-small cell lung cancer: influence on prognosis
por: Linhas, Ana Rita Diegues, et al.
Publicado: (2018)

Heterogeneous radiological response to chemotherapy is associated with poor prognosis in advanced non‐small‐cell lung cancer
por: Ryu, Woo Kyung, et al.
Publicado: (2021)

Plasma homocysteine is elevated in COPD patients and is related to COPD severity
por: Seemungal, Terence AR, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_qkd2iteonb6gb3vrg1gqtb0ptt